InvestorsHub Logo

HFM2

04/24/20 11:21 PM

#76201 RE: Decarz #76191

Certainly something to consider. I have read much of what has been published recently by the company and the two unanswered questions raised by the SEC are: 1) is there really a test, and 2)do/did they have access to production to match the numbers they projected early in the process? I believe the company will clarify via a PR and then the SEC can go back to whatever it does when no-one really cares. Then all the wrangling over what to do.

Natureboy1

04/25/20 3:15 AM

#76236 RE: Decarz #76191

I agree. If they show the devices to the SEC and demonstrate how quickly the impedance technology works and prove that they have manufacturing capabilities and a $12 million line of credit, they will be fine. The SEC isn’t in the business of shutting down established 18 year old companies with numerous employees that are only trying to help with Coronavirus testing. The government after all, ENCOURAGED them to enter this market. They were doing just fine with their diabetes test strips and worldwide distribution. Now they are gonna screw them over? It’s this simple. If the company is legit (and it is) there won’t be a problem. If it’s not, then it is a problem and they deserve what’s coming. It’s frustrating that it takes an act of God, for some of these people to understand a PROVEN science. Just because you’re not jamming q tips up your nose and waiting sometimes days for test results, doesn’t mean that the science is faulty. It just means it’s different. And yes, Bergman has perfected it and has the capabilities to produce millions of kits. He wouldn’t have said that otherwise. None of this helps investors though, contrary to what regulators may claim.

kommisar7

04/25/20 7:51 AM

#76257 RE: Decarz #76191

I also think of something like insider trading ....
the sale of tens of millions of shares when the pr is published is suspicious ....
maybe now you finally have clay trader at the wrap